COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,593 Articles (22,905 medRxiv, 8,688 bioRxiv)

Most recent first Previous |  Page 1094: Articles 10931-10940  | Next

Deficits in hospital care among clinically vulnerable children aged 0 to 4 years during the COVID-19 pandemic
Etoori, D., Harron, K., Mc Grath-Lone, L., Verfeurden, M., Gilbert, R., Blackburn, R.
10.1101/2021.12.16.21267904 — Posted: 2021-12-17
How effective is vaccination protection?
batista, m., Turnsek, A.
10.1101/2021.12.17.21267980 — Posted: 2021-12-17
Vaccines provide disproportional protection to the increased hospitalisation risk posed by the Delta variant of SARS-CoV2: a meta-analysis
Simons, M. J. P.
10.1101/2021.12.15.21267799 — Posted: 2021-12-17
A reliable and valid measure of COVID-19 patient-reported symptoms in outpatients: the Symptoms Evolution of COVID-19 (SE-C19) instrument
Rofail, D., Griffiths, P., Flore, G., Hussein, M., Sivapalasingam, S., Podolanczuk, A. J., Rodriguez, A. M., Mastey, V., Gwaltney, C.
10.1101/2021.12.16.21267708 — Posted: 2021-12-17
Comparative evaluation of rapid isothermal amplification and antigen assays for screening testing of SARS-CoV-2
Salcedo, N., Sena, B. F., Qu, X., Herrera, B. B.
10.1101/2021.12.16.21267796 — Posted: 2021-12-17
SAFETY PROFILE OF COVID-19 VACCINES IN PREGNANT AND POSTPARTUM WOMEN IN BRAZIL
Qiao, Y., Abreu, A., Dias, C. Z., Meng, X., Ferreira, R. V., Pereira, R. G., Julian, G. S., Yin, W.
10.1101/2021.12.14.21267777 — Posted: 2021-12-17
Persistence of immune response in health care workers after two doses BNT162b2 in a longitudinal observational study
Herzberg, J., Fischer, B., Lindenkamp, C., Becher, H., Becker, A.-K., Honarpisheh, H., Guraya, S. Y., Strate, T., Knabbe, C.
10.1101/2021.12.17.21267926 — Posted: 2021-12-17
Prolonged Detection of SARS CoV2 RNA in Extracellular Vesicles in Nasal Swab RT-PCR Negative Patients
Subudhi, P. D., Rooge, S., Thangriyal, S., Aggarwal, R., Gupta, E., Baweja, S.
10.1101/2021.12.16.21267912 — Posted: 2021-12-17
Predictors of SARS-CoV-2 infection in a multi-ethnic cohort of United Kingdom healthcare workers: a prospective nationwide cohort study (UK-REACH)
Martin, C. A., Pan, D., Melbourne, C., Teece, L., Aujayeb, A., Baggaley, R. F., Bryant, L., Carr, S., Gregary, B., Gupta, A., Guyatt, A. L., John, C., McManus, C., Nazareth, J., Nellums, L. B., Reza, R., Simpson, S., Tobin, M. D., Woolf, K., Zingwe, S., Khunti, K., Abrams, K. R., Gray, L. J., Pareek, M., UK-REACH Study Collaborative Group
10.1101/2021.12.16.21267934 — Posted: 2021-12-17
The Omicron variant mutation at position 28,311 in the SARS-CoV-2 N gene does not perturb CDC N1 target detection
Bei, Y., Vrtis, K. B., Borgaro, J. G., Langhorst, B. W., Nichols, N. M.
10.1101/2021.12.16.21267734 — Posted: 2021-12-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).